Baxter International Inc logo

Baxter International Inc

4
2
NYSE:BAX (USA)   Ordinary Shares
$ 41.54 -0.07 (-0.17%) 11:08 PM EST
7.96
P/B:
2.51
Market Cap:
$ 21.10B
Enterprise V:
$ 32.30B
Volume:
2.70M
Avg Vol (2M):
3.76M
Also Trade In:
Volume:
2.70M
Avg Vol (2M):
3.76M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Baxter International Inc ( ) from 1990 to Mar 19 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Baxter International stock (BAX) PE ratio as of Mar 19 2024 is 7.96. More Details

Baxter International Inc (BAX) PE Ratio (TTM) Chart

To

Baxter International Inc (BAX) PE Ratio (TTM) Historical Data

Total 1252
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Baxter International PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-03-19 8.0 2024-01-11 7.7
2024-03-15 8.0 2024-01-10 7.7
2024-03-14 8.1 2024-01-09 7.8
2024-03-13 8.2 2024-01-08 7.8
2024-03-12 8.2 2024-01-05 7.5
2024-03-11 8.3 2024-01-04 7.4
2024-03-08 8.4 2024-01-03 7.3
2024-03-07 8.3 2024-01-02 7.4
2024-03-06 8.2 2023-12-29 7.4
2024-03-05 8.1 2023-12-28 7.4
2024-03-04 8.1 2023-12-27 7.6
2024-03-01 7.9 2023-12-26 7.6
2024-02-29 7.8 2023-12-22 7.5
2024-02-28 8.0 2023-12-21 7.6
2024-02-27 8.0 2023-12-20 7.6
2024-02-26 8.1 2023-12-19 7.6
2024-02-23 8.2 2023-12-18 7.5
2024-02-22 8.1 2023-12-15 7.6
2024-02-21 8.1 2023-12-14 7.6
2024-02-20 8.0 2023-12-13 7.4
2024-02-16 7.9 2023-12-12 7.2
2024-02-15 7.8 2023-12-11 7.1
2024-02-14 7.6 2023-12-08 7.1
2024-02-13 7.6 2023-12-07 7.2
2024-02-12 7.7 2023-12-06 7.0
2024-02-09 7.6 2023-12-05 7.0
2024-02-08 7.8 2023-12-04 7.2
2024-02-07 7.5 2023-12-01 7.2
2024-02-06 7.6 2023-11-30 7.1
2024-02-05 7.4 2023-11-29 7.1
2024-02-02 7.5 2023-11-28 7.1
2024-02-01 7.5 2023-11-27 7.1
2024-01-31 7.4 2023-11-24 7.1
2024-01-30 7.4 2023-11-22 7.0
2024-01-29 7.5 2023-11-21 7.0
2024-01-26 7.4 2023-11-20 7.0
2024-01-25 7.5 2023-11-17 7.0
2024-01-24 7.3 2023-11-16 7.0
2024-01-23 7.4 2023-11-15 6.9
2024-01-22 7.4 2023-11-14 6.7
2024-01-19 7.4 2023-11-13 6.6
2024-01-18 7.4 2023-11-10 6.4
2024-01-17 7.4 2023-11-09 6.4
2024-01-16 7.5 2023-11-08 6.7
2024-01-12 7.7 2023-11-07 6.7

Baxter International Inc (BAX) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Baxter International Inc logo
Baxter International Inc
NAICS : 339112 SIC : 3841
ISIN : US0718131099

Share Class Description:

BAX: Ordinary Shares
Description
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app. From its legacy operations, Baxter offers tools to help patients with acute and chronic kidney failure, which it plans to spin off by mid-2024. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents.